TransEnterix (TRXC) Misses Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TransEnterix (TRXC) Granted FDA 510(k) Clearance for First Machine Vision System in Robotic Surgery
March 13, 2020 7:29 AM EDTTransEnterix, Inc. (NYSE: TRXC) announced the Company received 510(k) clearance for the Intelligent Surgical Unit (ISUTM) that enables machine vision capabilities on the Senhance Surgical System.
We are pleased to have received this important clearance earlier than expected. Machine vision is the next major advance in digital surgery, said Anthony Fernando, TransEnterix president and CEO. Our system is designed to significantly advance the sensing capabilities of computer-assisted surgery. With this hardware and software... More
